Lantern Pharma Inc.

LTRN

$1.87

-3.11%

2026-09-03 16:00:01 EDT-$0.06

Healthcare

Biotechnology

NASDAQ

Active Trading

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Loading executive datasets...

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Panna Sharma	President, Chief Executive Officer & Director	USD 763,750		1971	Active
David R. Margrave	Chief Financial Officer & Secretary	USD 540,780		1961	Active
Kishor Gopaldas Bhatia	Chief Scientific Officer & Scientific Consultant	USD 222,024	—	1955	Active
Peter L. Nara	Co-Founder & Advisor	—	—	—	Active
Marc C. Chamberlain	Chief Medical Officer of Starlight Therapeutics	—	—	—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of LTRN

RELATIONS

Upstream

Thermo Fisher Scientific Inc. (Patheon)NYSE:TMOCalifia Pharma Inc.Code Ocean Inc.

Downstream

Actuate Therapeutics Inc.NASDAQ:ACTUTTC Oncology LLCOregon TherapeuticsNational Cancer Institute (NCI/NIH)Johns Hopkins University (Brain Cancer Program)Fox Chase Cancer Center (Temple University Health)Bielefeld UniversityDeep Lens (acquired by Paradigm)withZeta.ai (Planned Spinout Entity)Unconfirmed

Proxies

Thermo Fisher Scientific Inc.NYSE:TMO Actuate Therapeutics Inc.NASDAQ:ACTU Recursion Pharmaceuticals Inc.NASDAQ:RXRX Schrödinger Inc.NASDAQ:SDGR

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer